Cytomegalovirus Infection
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection [Phase 2, Phase 3]
A Phase 2/3 efficacy study of human cytomegalovirus hyperimmune globulin to prevent congenital cytomegalovirus infection has completed its e…
-
CLINICAL_TRIALS research · 2011-11-11Clinical Trial Update: CMV Infection in Adolescent Males
A NIAID-sponsored clinical trial on cytomegalovirus infection in adolescent males has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-09-21Clinical Trial Update: Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients [Phase 4]
Phase 4 clinical trial update evaluating valganciclovir for cytomegalovirus infection in solid organ transplant patients; the study status i…
-
CLINICAL_TRIALS trial_result · 2011-09-20Clinical Trial Update: Recombinant CMV gB Vaccine in Postpartum Women [Phase 2]
Phase 2 clinical trial of a recombinant CMV glycoprotein B vaccine in postpartum women has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-15Clinical Trial Update: Reactivation of CMV Infection in Immunocompetent Patients Under Severe Stress
Clinical trial update regarding reactivation of Cytomegalovirus infection in immunocompetent patients under severe physiological stress. The…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: A Trial to Study How the Body Fights Off Cytomegalovirus (CMV) in Hematopoietic Transplant Recipients.
The Mayo Clinic-sponsored clinical trial studying how the immune system fights cytomegalovirus in hematopoietic transplant recipients has co…
-
CLINICAL_TRIALS research · 2011-05-12Clinical Trial Update: Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection
This clinical trial update compares two immunosuppressive regimens in deceased-donor kidney transplant recipients to prevent graft fibrosis/…
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients [Phase 3]
Phase 3 study evaluating valacyclovir hydrochloride to prevent life-threatening cytomegalovirus disease in HIV-infected patients has complet…
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis
GlaxoSmithKline-sponsored seroprevalence study assessing antibodies to Hepatitis A, Varicella-zoster virus, Cytomegalovirus, Herpes simplex,…
-
CLINICAL_TRIALS research · 2010-11-25Clinical Trial Update: The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis
Clinical trial update examining the prevalence of cytomegalovirus, Epstein-Barr virus, and HHV-6 in the saliva of a patient with periodontit…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation [Phase 3]
A Phase 3 trial evaluated valacyclovir to prevent cytomegalovirus infection in patients undergoing donor stem cell transplantation. The stud…
-
CLINICAL_TRIALS trial_result · 2010-08-24Clinical Trial Update: Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection
A clinical trial update describes emergency use of adoptive CMV-specific T cell therapy following donor bone marrow transplant in an infant …
-
FDA approval · 2010-08-05FDA Approved: VALCYTE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for VALCYTE (valganciclovir hydrochloride) submitted by H2-Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients [Phase 3]
Phase 3 trial of valganciclovir (Valcyte) for prevention of cytomegalovirus disease in kidney transplant recipients completed; results were …
-
FDA approval · 2010-06-21FDA Approved: GANCICLOVIR — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA, LLC's original application for GANCICLOVIR SODIUM (ganciclovir), marking a generic approval.
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating Cytomegalovirus hyperimmune globulin (CMV-Ig) replacement in hypogammaglobulinemic lung transplant recipien…
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation [Phase 3]
Phase 3 trial evaluating valganciclovir to prevent cytomegalovirus infection after donor stem cell transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-19Clinical Trial Update: CMV Glycoprotein B Vaccine in Allograft Recipients [Phase 2]
Phase 2 trial evaluating a cytomegalovirus glycoprotein B vaccine in allogeneic transplant recipients is ongoing; current status of the stud…
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: TAMOVALCIR in Allogenic Hematopoietic Progenitors Transplant [Phase 2]
Completed Phase 2 trial of TAMOVALCIR in allogeneic hematopoietic progenitor transplant to address cytomegalovirus infection.
-
FDA approval · 2009-08-28FDA Approved: VALCYTE — Original Application (H2-Pharma, LLC)
FDA approved VALCYTE (valganciclovir hydrochloride) under the original application for cytomegalovirus infections, including CMV retinitis i…
-
CLINICAL_TRIALS research · 2009-08-27Clinical Trial Update: Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy [Phase 3]
Phase 3 clinical trial evaluating prevention of cardiac allograft vasculopathy in heart transplant recipients using everolimus in combinatio…
-
FDA approval · 2009-02-26FDA Approved: GANCICLOVIR — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for ganciclovir sodium (generic ganciclovir) submitted by Hikma Pharmaceuticals USA Inc., under ANDA…
-
CLINICAL_TRIALS trial_result · 2009-02-03Clinical Trial Update: CMV Disease and IRIS in HIV-1 Infected Persons
A completed clinical trial investigating cytomegalovirus disease and IRIS in persons infected with HIV-1.
-
CLINICAL_TRIALS trial_result · 2008-12-30Clinical Trial Update: Detection of Human Cytomegalovirus in the Saliva
A completed clinical trial reports on detecting human cytomegalovirus in saliva, describing the methodology and findings.
-
CLINICAL_TRIALS trial_result · 2008-11-10Clinical Trial Update: A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV) [Phase 1]
Phase 1 trial of an Alphavirus replicon vaccine for Cytomegalovirus has completed.